These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 34486081

  • 1. Recurrence of gastric gastrointestinal stromal tumor 12 years after repeat hepatectomies for liver metastases: report of a case.
    Fujinaga A, Ohta M, Masuda T, Itai Y, Nakanuma H, Kawasaki T, Kawano Y, Hirashita T, Endo Y, Inomata M.
    Clin J Gastroenterol; 2021 Dec; 14(6):1637-1641. PubMed ID: 34486081
    [Abstract] [Full Text] [Related]

  • 2. [A Case of GIST of the Stomach with Long-Term Survival after Multidisciplinary Treatment, Including Four Surgical Resections of Liver Metastases].
    Kitakaze M, Hirao M, Miyamoto A, Hamakawa T, Yamamoto K, Nishikawa K, Maeda S, Uemura M, Miyake M, Hama N, Miyazaki M, Ikeda M, Nakamori S, Kiyokawa H, Mano M, Sekimoto M.
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2237-2239. PubMed ID: 28133281
    [Abstract] [Full Text] [Related]

  • 3. A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome.
    Zhu J, Yang Y, Zhou L, Jiang M, Hou M.
    BMC Cancer; 2010 May 13; 10():199. PubMed ID: 20465813
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.
    Kimura T, Togawa T, Onishi K, Iida A, Sato Y, Goi T.
    J Investig Med High Impact Case Rep; 2020 May 13; 8():2324709620970736. PubMed ID: 33228387
    [Abstract] [Full Text] [Related]

  • 5. Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China.
    Shi YN, Li Y, Wang LP, Wang ZH, Liang XB, Liang H, Zhang L, Li B, Fan LQ, Zhao Q, Ma ZX, Zhao XF, Zhang ZD, Liu Y, Tan BB, Wang D, Wang LL, Hao YJ, Jia N.
    Medicine (Baltimore); 2017 Nov 13; 96(46):e8240. PubMed ID: 29145240
    [Abstract] [Full Text] [Related]

  • 6. Secondary c-kit mutation in a recurrent gastrointestinal stromal tumor under long-term treatment with imatinib mesylate: report of a case.
    Utsunomiya T, Okamoto M, Yano S, Kameyama T, Matsuyama A, Kuma S, Yamamoto M, Fujiwara M, Ishida T.
    Surg Today; 2008 Nov 13; 38(1):65-7. PubMed ID: 18085368
    [Abstract] [Full Text] [Related]

  • 7. Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.
    DeMatteo RP, Ballman KV, Antonescu CR, Corless C, Kolesnikova V, von Mehren M, McCarter MD, Norton J, Maki RG, Pisters PW, Demetri GD, Brennan MF, Owzar K, American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team for the Alliance for Clinical Trials in Oncology.
    Ann Surg; 2013 Sep 13; 258(3):422-9. PubMed ID: 23860199
    [Abstract] [Full Text] [Related]

  • 8. [A Case of Multiple Liver Metastases and Peritoneal Dissemination after Resection of a Gastrointestinal Stromal Tumor of the Stomach Successfully Treated with Imatinib Mesylate].
    Ogasawara T, Shida T, Nomura S, Takahara Y, Uno H, Takahashi M, Komatsu T.
    Gan To Kagaku Ryoho; 2015 Nov 13; 42(12):1959-61. PubMed ID: 26805230
    [Abstract] [Full Text] [Related]

  • 9. [A Case of Long-Term Survival after Multimodal Therapy against Gastric GIST with Multiple Hepatic Metastasis].
    Ikenaga N, Takahashi T, Nakajima K, Kurokawa Y, Saito T, Yamamoto K, Yamashita K, Tanaka K, Makino T, Yamasaki M, Eguchi H, Dok I Y.
    Gan To Kagaku Ryoho; 2022 Feb 13; 49(2):214-216. PubMed ID: 35249065
    [Abstract] [Full Text] [Related]

  • 10. [A case of recurrent duodenal gastrointestinal stromal tumor resistant to imatinib and sunitinib, successfully treated with regorafenib].
    Takeda Y, Nakahira S, Katsura Y, Ohmura Y, Kusama H, Kuroda Y, Goto T, Hashimoto T, Kimura K, Matsushita K, Sato Y, Morimoto Y, Ishida T, Nitta K, Kagawa Y, Okishiro M, Takeno A, Sakisaka H, Taniguchi H, Egawa C, Ohzono K, Nakatsuka S, Kato T, Tamura S.
    Gan To Kagaku Ryoho; 2014 Nov 13; 41(12):1545-7. PubMed ID: 25731247
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
    Wan WZ, Zhang P, Zeng XY, Zhou H, Lin Y, Xiong Z, Zhang RZ, Liu WZ, Han Y, Tao KX.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep 25; 22(9):848-855. PubMed ID: 31550824
    [Abstract] [Full Text] [Related]

  • 12. [A Case of Gastrointestinal Stromal Tumor Re-Resected Ten Years after the Resection of Its Recurrence].
    Aida T, Shiobara M, Wakatsuki K, Ogasawara T, Suda K, Miyazawa K, Miyoshi T, Sato S, Yoshioka S, Yamazaki K.
    Gan To Kagaku Ryoho; 2019 Dec 25; 46(13):1943-1944. PubMed ID: 32157020
    [Abstract] [Full Text] [Related]

  • 13. [Adherence to adjuvant with therapy imatinib in patients with gastrointestinal stromal tumor: a national multi-center cross-sectional study].
    Zhang P, Zhang J, Zhang B, Yang WC, Hu JB, Sun XF, Zhai G, Qian HR, Li Y, Xu H, Feng F, Wu XY, Liu HL, Liu HJ, Qiu HB, Wu XJ, Zhou YB, Shen KT, Kou YW, Fu Y, Jie ZG, Zou XM, Cao H, Gao ZD, Tao KX.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep 25; 24(9):775-782. PubMed ID: 34530558
    [Abstract] [Full Text] [Related]

  • 14. [A Case of Recurrent Gastric GIST Who Survived for Long after Laparoscopic Resection and Imatinib Therapy].
    Yabe N, Takenoya T, Oto I, Harada Y, Kondo A, Ogiso M, Maeda H, Asada Y, Sako H, Yoshikawa T, Osumi K, Kamiya N, Sotome K, Ishii Y, Watanabe M.
    Gan To Kagaku Ryoho; 2023 Dec 25; 50(13):1718-1720. PubMed ID: 38303184
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy observation on imatinib reintroduction in gastrointestinal stromal tumor with high recurrence risk after imatinib adjuvant therapy failure].
    Dong Z, Gao J, Gong J, Li J, Li Y, Wang X, Li Y, Shen L, Li J.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov 25; 19(11):1286-1289. PubMed ID: 27928801
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
    Joensuu H, Eriksson M, Hall KS, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Ballman KV, Leinonen M, DeMatteo RP, Reichardt P.
    Cancer; 2014 Aug 01; 120(15):2325-33. PubMed ID: 24737415
    [Abstract] [Full Text] [Related]

  • 17. [A Case of HER2-Positive Recurrent Breast Cancer and Liver Metastases of GIST Treated with Combined Anti-HER2 Therapy and Imatinib].
    Uchida H, Toshikawa C, Moro K, Ishikawa T, Obata Y, Tsuchida J, Nagahashi M, Ichikawa H, Hanyu T, Takizawa K, Shimada Y, Sakata J, Umezu H, Koyama Y, Wakai T.
    Gan To Kagaku Ryoho; 2021 Dec 01; 48(13):1725-1727. PubMed ID: 35046310
    [Abstract] [Full Text] [Related]

  • 18. Pathologic complete response confirmed by surgical resection for liver metastases of gastrointestinal stromal tumor after treatment with imatinib mesylate.
    Suzuki S, Sasajima K, Miyamoto M, Watanabe H, Yokoyama T, Maruyama H, Matsutani T, Liu A, Hosone M, Maeda S, Tajiri T.
    World J Gastroenterol; 2008 Jun 21; 14(23):3763-7. PubMed ID: 18595147
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
    Raut CP, Espat NJ, Maki RG, Araujo DM, Trent J, Williams TF, Purkayastha DD, DeMatteo RP.
    JAMA Oncol; 2018 Dec 01; 4(12):e184060. PubMed ID: 30383140
    [Abstract] [Full Text] [Related]

  • 20. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with KIT/PDGFRA gene "homozygous mutation": a multicenter retrospective cohort study].
    Shen YY, Li XQ, Yang LX, Fang Y, Nie MM, He ZR, Hou YY, Cao H, Wang M, Shen KT.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep 25; 24(9):804-813. PubMed ID: 34530562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.